CV Sciences Stock Faces Volatility: 52‑Week Low & Negative P/E Reveal Investor Challenges
CV Sciences Inc. sees volatile OTC stock, blending consumer personal‑care and specialty pharma; investors watch its low‑priced, loss‑bearing outlook.
2 minutes to read